Evidence map›Paper›PMID 35693445›Full record

ReviewSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2022

Role of site-directed mutagenesis and adjuvants in the stability and potency of anthrax protective antigen.

Mohammed Ali Dahhas, Mohammad A Alsenaidy

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Human anthrax vaccines: Current status and future prospects.Human vaccines & immunotherapeutics · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Inverse PCR for Site-Directed Mutagenesis.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed Ali DahhasDepartment of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Mohammad A AlsenaidyDepartment of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthrax is a zoonotic infection caused by the gram-positive, aerobic, spore-forming bacterium

Indexed as

Adjuvant formulationsAdjuvantsAl(OH)3, Aluminum hydroxideAlOH, Aluminum oxyhydroxideAlPO4, Aluminum phosphateAluminum adjuvantsAnthraxAsn, AsparagineAVA, Anthrax Vaccine AdsorbedAVP, Anthrax vaccine precipitatedBacillus anthraciscAMP, cyclic AMPCMG2, Capillary morphogenesis proteinCpG-ODN, Synthetic oligodeoxynucleotides containing unmethylated cytosine phosphoguanineDeamidationdm, Double mutantsEF, Edema factorGln, GlutamineGly, GlycineInstabilityLF, Lethal factorMPLA, Monophosphoryl lipid APA, Protective antigenProtective antigenrPA, Recombinant PASer, SerineTEM8, Tumor endothelial marker 8TLR, Toll-like receptorWT, Wild type

Identifiers

PMID35693445
PMCPMC9177452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.